ARCHIVES

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

Proteomics Promises Ways To Track Response To Therapy

April 25, 2003

NIAID Advisors Ok Recompetition of Pediatric ACTGs

February 14, 1992

Skin Cancer Screens Find “Extraordinary High” Rates

September 20, 1985

ACS Professors; Connie Mack Is Chairman Of Moffitt Board.

February 9, 2001

ACS Creates $1 Billion Nationwide Organization, Taking Fiduciary Control From 12 Divisions

November 18, 2011

Funding Opporunities: Program Announcments

January 15, 1999